Exploratory aims Exploratory aims are to evaluate the change from baseline that treatment with 400 mg oral SAMe for 180 days has, compared to placebo, on 1) blood total tau, amyloid-, and neurofilament light levels, and 2) cognitive status as assessed by the Standardized MiniMental State Examination, Cognitive Dementia Rating, California Verbal Learning Test 3rd Edition, Montreal Cognitive Assessment, and Digit Symbol Substitution Test
Diniz, Auburn University, United States Reviewed by Alison Ward, University of Saskatchewan, Canada Gastn Alfaro, National University of Cordoba, Argentina Updates Copyright 2025 Costa, Nascimento, Dans, Gionbelli and Duarte
Generous Practical: The 130g 4.586oz jar offers good value, providing a substantial amount of product for consistent daily use
What Is in the Vial Each order is an 80mg KLOW blend vial of lyophilized powder listed at $240 through Peptide Partners, a US-based vendor that typically ships within about two business days